DOCA-PHARMA
ActiveSummary
DOCA-PHARMA has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€79,753) and a net result of -€64,546. Its solvency ranks better than 5% of 1,583 sector peers (NACE 75, financial year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- DOCA-PHARMA
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest, 9112 Sint-Niklaas (Sinaai),Edgard Tinelstraat 11” (deed in Dutch)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- One provision in the deed
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Gelijk recht in de winstverdeling en in het vereffeningsaldo, ieder aandeel” (deed in Dutch)
- Share issue ruleHow and by whom new shares can be issued.
- “Inbreng in geld met uitgifte van nieuwe aandelen – recht van voorkeur, 15” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- “uit op basis van de door de volmachtgever verstrekte informatie. • Voor al het voormelde mag de volmachtdrager alle verklaringen doen, alle…” (deed in Dutch)